Santen Pharmaceutical Co. Ltd.

LEI 529900TPT3I7C17MIM03

Legal Address [ja-JP]

Shimoshinjo 3-9-19
Osaka JP-27 JP 533-0021

Headquarters Address [ja-JP]

4-20 Ofuka-cho, Kita-ku
Osaka JP-27 JP 530-8552

External Public Records

LEI Registration Details

L E I

529900TPT3I7C17MIM03

Legal Name

Santen Pharmaceutical Co. Ltd.

Authority Authority I D

RA000412

Authority Authority I D

1200-01-051819

Legal Jurisdiction

Legal Form Legal Form Code

T417

Status

ACTIVE

Initial Date

2019-03-01 03:59:47

Last Update Date

2021-07-19 07:07:28

Status

LAPSED

Next Renewal Date

2020-03-01 03:59:47

Managing L O U

5299000J2N45DDNE4Y28 [Herausgebergemeinschaft Wertpapier-Mitteilungen Keppler, Lehmann GmbH & Co. KG]

Validation Sources

FULLY_CORROBORATED

Validation Authority Validation Authority I D

RA000412

Validation Authority Validation Authority I D

1200-01-051819

LEI Registration Exception(s)

Direct Accounting Consolidation Parent: No Known Person
Ultimate Accounting Consolidation Parent: No Known Person

Subsidiaries and Parent Companies

Subsidiaries

SANTEN PHARMACEUTICAL SPAIN SL

Relationship Details

Business Entity Relationship

Active

Santen Pharmaceutical Spain Sl is ultimately consolidated by Santen Pharmaceutical Co. Ltd.

Relationship Start Node Node I D

959800KWNTB2NDZCUC86 [SANTEN PHARMACEUTICAL SPAIN SL]

Relationship End Node Node I D

529900TPT3I7C17MIM03 [Santen Pharmaceutical Co. Ltd.]

Relationship Relationship Type

Is Ultimately Consolidated By

Relationship Relationship Status

Active

Registration Initial Registration Date

2021-04-16 09:15:59

Registration Last Update Date

2021-04-16 09:15:59

Registration Registration Status

Published

Registration Next Renewal Date

2022-04-16 02:50:54

Registration Managing L O U

959800R2X69K6Y6MX775 []

Registration Validation Sources

Entity Supplied Only

Registration Validation Documents

ISIN Codes Assigned (2)

ISIN:

JP3336000009

ISIN:

US80287P1003